Invention Grant
- Patent Title: Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
-
Application No.: US14592022Application Date: 2015-01-08
-
Publication No.: US09969805B2Publication Date: 2018-05-15
- Inventor: Hilde Adi Pierrette Revets , Carlo Boutton , Hendricus Renerus Jacobus Mattheus Hoogenboom
- Applicant: Ablynx N.V.
- Applicant Address: BE Ghent-Zwijnaarde
- Assignee: Ablynx N.V.
- Current Assignee: Ablynx N.V.
- Current Assignee Address: BE Ghent-Zwijnaarde
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K39/00
Abstract:
The present invention relates to amino acid sequences and Nanobodies that are directed against Epidermal Growth Factor Receptor 2 (HER2), as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences.
Public/Granted literature
Information query
